Breaking News, Collaborations & Alliances

Jubilant Biosys, Sanofi Expand Collaboration

Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant Biosys, a Bengaluru-based subsidiary of Jubilant Life Sciences, has formed a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with Sanofi started in 2016, to discover and develop small molecule inhibitors for multiple targets in the metabolic disorders therapeutic area.   The new research collaboration is aimed at discovering therapeutic small molecules that will address unmet needs in neurological diseases. Jubilant Biosys wil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters